Jaxon Mining Inc.

  • ISIN: CA47200C1023
  • Land: .

Nachricht vom 14.11.2017 | 15:15

Jaxon Closes First Tranche of Flow Through Financing

DGAP-News: Jaxon Mining Inc. / Key word(s): Miscellaneous

14.11.2017 / 15:15
The issuer is solely responsible for the content of this announcement.


Vancouver, British Columbia--(Newsfile Corp. - November 14, 2017) - Jaxon Mining Inc. (TSXV: JAX) (FSE: OU31) is pleased to announce it has closed the first tranche of a non-brokered private placement announced October 26, 2017. This tranche consisted of gross proceeds of $695,652. The flow-through shares are part of a donation arrangement structured by PearTree Securities Inc. through which the institutional end-buyer is the ultimate holder of the flow-through shares.

Jason Cubitt, president of Jaxon Mining, commented: 'We appreciate the ongoing support of our investors and look forward to continued exploration success at both the Hazelton and More Creek projects.'

Jaxon issued 2,173,914 flow-through shares at a price of $0.32 in this tranche. All shares from this placement are subject to a four-month hold from the date of issuance. The private placement is subject to final TSX Venture approval.

Proceeds will be used to continue the drilling program underway at Jaxon's Hazelton Project on the Max VMS Target, and will also be applied to other precious and base metal targets at Hazelton as well as the company's More Creek Project in the Golden Triangle.

About Jaxon

Jaxon is a precious and base metals exploration company with a regional focus on Western Canada. The company is currently focused on advancing its Hazelton Project in north-central British Columbia and the More Creek Project (consolidating the Wishbone and Foremore properties) in BC's Golden Triangle.

ON BEHALF OF THE BOARD OF DIRECTORS
JAXON MINING INC.

'Jason Cubitt'                 
Jason Cubitt, President.

For further information regarding Jaxon Mining Inc., please contact Mark Carruthers at 604-608-0400 
Toll free: 1-877-608-0007.

This news release may contain forward-looking information, which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the Company's objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company's public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames, or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. Neither TSX Venture exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange accepts responsibility for the adequacy or accuracy of this release.

Click on, or paste the following link into your web browser, to view the associated documents http://www.newsfilecorp.com/release/30451


14.11.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

M1 Kliniken AG: Kursziel angehoben

Die M1 Kliniken AG hat den eingeschlagenen Wachstumskurs mit einem Umsatzanstieg von 20,3 % auch im ersten Halbjahr fortgesetzt. Analog dazu gelang es der Gesellschaft, einen überproportionalen Anstieg des EBIT um 36,5% zu erreichen und unsere Erwartungen zu übertreffen. Wir haben auf dieser Grundlage unsere Umsatz- und Ergebnisschätzungen angehoben. Bei einem Kursziel von 16,15 € ergibt sich ein hohes Kurspotenzial - damit lautet das Rating KAUFEN.

News im Fokus

ProSiebenSat.1 Media SE: Thomas Ebeling verlässt das Unternehmen Ende Februar 2018

19. November 2017, 19:10

Aktueller Webcast

ADO Properties S.A.

9M RESULTS 2017

15. November 2017

Aktuelle Research-Studie

MOLOGEN AG

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

20. November 2017